These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25130049)

  • 1. Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses.
    Keith PJ; Wetter DA; Wilson JW; Lehman JS
    Br J Dermatol; 2014 Dec; 171(6):1307-17. PubMed ID: 25130049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for infections prior to initiating immunosuppressive treatment for patients with autoimmune blistering diseases.
    Murrell DF
    Br J Dermatol; 2014 Dec; 171(6):1285-6. PubMed ID: 25523248
    [No Abstract]   [Full Text] [Related]  

  • 3. Literature-based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses.
    Laniosz V; Lehman JS; Poland GA; Wetter DA
    Int J Dermatol; 2016 Jun; 55(6):599-607. PubMed ID: 26711431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders.
    Lehman JS; Murrell DF; Camilleri MJ; Kalaaji AN
    Dermatol Clin; 2011 Oct; 29(4):591-8. PubMed ID: 21925003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M; David M; Mimouni D
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bullous autoimmune dermatoses. 3: Diagnosis and therapy].
    Hertl M; Schuler G
    Hautarzt; 2002 May; 53(5):352-65; quiz 366-7. PubMed ID: 12063750
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune bullous dermatoses in the elderly: diagnosis and management.
    Mutasim DF
    Drugs Aging; 2003; 20(9):663-81. PubMed ID: 12831291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blistering autoimmune dermatoses (II): therapy].
    Goebeler M; Sitaru C; Zillikens D
    J Dtsch Dermatol Ges; 2004 Sep; 2(9):774-91; quiz 792-3. PubMed ID: 16279223
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies.
    Schiavo AL; Puca RV; Ruocco V; Ruocco E
    Clin Dermatol; 2010; 28(3):337-43. PubMed ID: 20541689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.
    Hertl M; Zillikens D; Borradori L; Bruckner-Tuderman L; Burckhard H; Eming R; Engert A; Goebeler M; Hofmann S; Hunzelmann N; Karlhofer F; Kautz O; Lippert U; Niedermeier A; Nitschke M; Pfütze M; Reiser M; Rose C; Schmidt E; Shimanovich I; Sticherling M; Wolff-Franke S
    J Dtsch Dermatol Ges; 2008 May; 6(5):366-73. PubMed ID: 18201220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M; David M; Mimouni D
    Immunol Allergy Clin North Am; 2012 May; 32(2):309-15, vii. PubMed ID: 22560143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy.
    Kneisel A; Hertl M
    J Dtsch Dermatol Ges; 2011 Nov; 9(11):927-47. PubMed ID: 22026362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acquired bullous skin diseases.
    Fine JD
    N Engl J Med; 1995 Nov; 333(22):1475-84. PubMed ID: 7477149
    [No Abstract]   [Full Text] [Related]  

  • 14. [Item 116--Autoimmune bullous dermatoses].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A94-101. PubMed ID: 23176869
    [No Abstract]   [Full Text] [Related]  

  • 15. Dapsone in the management of autoimmune bullous diseases.
    Piette EW; Werth VP
    Dermatol Clin; 2011 Oct; 29(4):561-4. PubMed ID: 21924998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linear IgA bullous dermatosis responsive to trimethoprim-sulfamethoxazole.
    Peterson JD; Chan LS
    Clin Exp Dermatol; 2007 Nov; 32(6):756-8. PubMed ID: 17868394
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune blistering diseases: incidence and treatment in Croatia.
    Marinovic B; Lipozencic J; Jukic IL
    Dermatol Clin; 2011 Oct; 29(4):677-9. PubMed ID: 21925017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of autoimmune blistering diseases.
    Levy M; Rico MJ
    Dermatol Clin; 1999 Apr; 17(2):431-40, x. PubMed ID: 10327307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blistering diseases in neonates.
    Zhao CY; Murrell DF
    Curr Opin Pediatr; 2016 Aug; 28(4):500-6. PubMed ID: 27386969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Linear IgA bullous dermatosis: a review].
    Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2011 Mar; 138(3):214-20. PubMed ID: 21397151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.